Drugs / ASP0892
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03755713 | Mar 2019 → Oct 2021 | food allergy | Astellas Pharma Global Development, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT02851277 | Dec 2016 → Dec 2018 | food allergy | Astellas Pharma Global Development, Inc. | Completed | No outcome recorded |
News releases announcing trial results or a regulatory action · 1
| Date | Issuer | Release |
|---|---|---|
| 2016-12-20 | Astellas Pharma Inc | Regulatory Astellas Announces FDA Fast Track Designation for ASP0892, DNA Vaccine for Mitigation of Severe Hypersensitivity Reactions due to Peanut Allergy astellas.com ↗
Tokyo, December 20, 2016 - Astellas Pharma Inc. (President and CEO: Yoshihiko Hatanaka, “Astellas”) and Immunomic Therapeutics, Inc. (Founder & CEO: William Hearl, Ph.D., “Immunomic Therapeutics”) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the drug candidate ASP0892 for the mitigation of severe hypersensitivity reactions due to peanut allergy. |
All press releases naming this drug 2 releases
| Date | Issuer | Release |
|---|---|---|
| 2021-06-17 | Astellas Pharma Inc | Notice Regarding Impairment Loss Following the Termination of DNA Vaccine ASP0892 Development astellas.com ↗ |
| 2016-12-20 | Astellas Pharma Inc | Astellas Announces FDA Fast Track Designation for ASP0892, DNA Vaccine for Mitigation of Severe Hypersensitivity Reactions due to Peanut Allergy astellas.com ↗ |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ASP0892 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03755713 ↗ |
| Known as | ARA-LAMP-vax | “ASP0892 (ARA-LAMP-vax), a Single Multivalent Peanut (Ara h1, h2, h3) Lysosomal Associated Membrane Protein DNA Plasmid Vaccine” NCT03755713 ↗1“ASP0892 (ARA-LAMP-vax), a single multivalent peanut (Ara h1, h2, h3) Lysosomal Associated Membrane Protein DNA Plasmid Vaccine” NCT02851277 ↗ |
| Modality | Vaccine | “ASP0892, a peanut DNA vaccine” PMID 38010254 ↗ Nov 2023 |